Cargando…
Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
Background and Objectives: Aspirin (acetylsalicylic acid—ASA) is a first-line antiplatelet therapy provided to patients with coronary artery disease (CAD). However, it has been demonstrated that 20–30% of these patients are non-sensitive to their ASA therapy. ASA non-sensitivity is a phenomenon wher...
Autores principales: | Khan, Hamzah, Gallant, Reid, Jain, Shubha, Al-Omran, Mohammed, De Mestral, Charles, Greco, Elisa, Wheatcroft, Mark, Alazonni, Ashraf, Abdin, Rawand, Rand, Margaret L., Ni, Heyu, Qadura, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600331/ https://www.ncbi.nlm.nih.gov/pubmed/33023261 http://dx.doi.org/10.3390/medicina56100519 |
Ejemplares similares
-
Plateletworks(®) as a Point-of-Care Test for ASA Non-Sensitivity
por: Khan, Hamzah, et al.
Publicado: (2021) -
Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022) -
Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
por: Khan, Hamzah, et al.
Publicado: (2021) -
Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
por: Khan, Hamzah, et al.
Publicado: (2020) -
Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients
por: Zamzam, Abdelrahman, et al.
Publicado: (2020)